FierceBiotech FierceBiotech IT FiercePharma FierceMedicalDevices
FierceBiotech Research FierceVaccines FiercePharma Manufacturing FierceDrugDelivery

Related Tags >> tender offer   Shareholders   Goldman Sachs   Genzyme
Syndicate content

Securities And Exchange Commission News

Most Popular Securities And Exchange Commission Story

Did Stiefel undervalue employee shares before GSK buyout?

Was something rotten in Stiefel Laboratories' dealings with employee-shareholders before its sale to GlaxoSmithKline ($GSK)? The Securities and Exchange Commission believes so. The U.S. agency Read more...

Latest Headlines